ANKRD22 Activators
ANKRD22 Activators comprise a diverse array of chemical compounds that indirectly bolster the functional dynamics of ANKRD22 via distinct signaling pathways, ensuring a multifaceted approach to the enhancement of its activity. Forskolin, through its ability to elevate cAMP levels, and Sildenafil, by increasing cGMP levels, both potentiate the activation of PKA and PKG respectively, which could lead to the phosphorylation and subsequent activation of ANKRD22. The mechanism of action is further diversified with PMA, a PKC activator that could similarly induce phosphorylation events that enhance ANKRD22's functionality within signaling cascades. Additionally, ionomycin, by increasing intracellular calcium, could activate calcium-dependent kinases that may target ANKRD22 for activation, while A23187, another calcium ionophore, might elicit an analogous effect on the protein's activity.
The regulatory influence extends to the polyamine spermine, which can alter ion channel status and thus the cellular milieu, potentially priming ANKRD22 for enhanced activity. Epigallocatechin Gallate (EGCG) strategically inhibits certain kinases, potentially reducing competitive inhibitory phosphorylation and favoring ANKRD22 activity enhancement. The PI3K inhibitor LY294002 alters the AKT pathway, potentially provoking a cellular response that upregulates ANKRD22 activity.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin directly stimulates adenylyl cyclase, increasing intracellular cAMP levels. This elevation in cAMP activates protein kinase A (PKA), which could phosphorylate ANKRD22, leading to its functional enhancement. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin acts as a calcium ionophore, raising intracellular calcium levels. The increase in calcium can activate calcineurin and other calcium-dependent kinases, which may phosphorylate and enhance ANKRD22 activity. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is a diacylglycerol analog that activates protein kinase C (PKC) isoforms. PKC-mediated phosphorylation can lead to changes in the functional state of ANKRD22, resulting in its activation. | ||||||
Spermine | 71-44-3 | sc-212953A sc-212953 sc-212953B sc-212953C | 1 g 5 g 25 g 100 g | $61.00 $196.00 $277.00 $901.00 | 1 | |
Spermine affects cellular polyamine levels and may modulate ion channels. These changes can alter the cellular environment in a way that enhances ANKRD22's functional state. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG is a polyphenol that inhibits certain protein kinases. This inhibition can relieve inhibitory phosphorylation on other proteins, potentially leading to an upregulation of ANKRD22 activity. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor that can lead to reduced AKT phosphorylation and activation. This may cause a compensatory response that enhances ANKRD22 activity through alternative pathways. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 is a calcium ionophore that increases intracellular calcium, which can activate calcium-driven signaling enzymes that may enhance ANKRD22's activity. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is an inhibitor of p38 MAPK. By inhibiting p38, it may lead to the activation of alternative pathways that could enhance the functional activity of ANKRD22. | ||||||
Zaprinast (M&B 22948) | 37762-06-4 | sc-201206 sc-201206A | 25 mg 100 mg | $105.00 $250.00 | 8 | |
Zaprinast inhibits PDE5, increasing cGMP levels, which may enhance PKG activity. PKG, in turn, could phosphorylate ANKRD22, enhancing its activity. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
Rolipram is a selective inhibitor of PDE4. Elevated cAMP levels following PDE4 inhibition can activate PKA, which may lead to enhanced phosphorylation and activity of ANKRD22. | ||||||